Cargando…
Association of Administration of Surfactant Using Less Invasive Methods With Outcomes in Extremely Preterm Infants Less Than 27 Weeks of Gestation
IMPORTANCE: The inclusion of less invasive surfactant administration (LISA) in the care of preterm infants has been found to be beneficial for respiratory outcomes. Recently, the OPTIMIST trial found higher mortality rates in the subgroup of infants born at 25 to 26 weeks’ gestational age (GA) who r...
Autores principales: | Härtel, Christoph, Herting, Egbert, Humberg, Alexander, Hanke, Kathrin, Mehler, Katrin, Keller, Titus, Mauer, Isabell, Frieauff, Eric, Meyer, Sascha, Thome, Ulrich H., Wieg, Christian, Schmidtke, Susanne, Kribs, Angela, Göpel, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364126/ https://www.ncbi.nlm.nih.gov/pubmed/35943742 http://dx.doi.org/10.1001/jamanetworkopen.2022.25810 |
Ejemplares similares
-
Less invasive surfactant administration and complications of preterm birth
por: Härtel, Christoph, et al.
Publicado: (2018) -
Less invasive surfactant administration (LISA): chances and limitations
por: Herting, Egbert, et al.
Publicado: (2019) -
Less invasive surfactant administration: best practices and unanswered questions
por: Herting, Egbert, et al.
Publicado: (2020) -
Two-year outcome data suggest that less invasive surfactant administration (LISA) is safe. Results from the follow-up of the randomized controlled AMV (avoid mechanical ventilation) study
por: Herting, Egbert, et al.
Publicado: (2020) -
A randomised controlled trial in preterm infants comparing prophylactic with selective “less invasive surfactant administration” (pro.LISA)
por: Göpel, Wolfgang, et al.
Publicado: (2023)